<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">31773386</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>52</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International urology and nephrology</Title>
                <ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>137-145</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-019-02336-6</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION AND PURPOSE" NlmCategory="OBJECTIVE">Arterial stiffness is an independent predictor of cardiovascular disease in chronic kidney disease (CKD). Cardio-ankle vascular index (CAVI) is a newly developed method used to assess arterial stiffness, independent of changes in blood pressure. CAVI reflects stiffness and atherosclerosis at the thoracic, abdominal, common iliac, femoral, and tibial artery levels. In predialysis stage 3-5 diabetic and nondiabetic CKD patients, CAVI levels and its relation to atherosclerosis-associated risk factors including monocyte-chemoattractant protein-1 (MCP-1), sclerostin, fibroblast growth factor-23 (FGF-23), Klotho, and 25-OH vitamin D were determined.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study was performed on three age-matched and gender-matched groups. Group 1 included 46 stage 3-5 nondiabetic CKD patients, group 2 included 44 stage 3-5 diabetic CKD patients, and group 3 included 44 non-uremic controls. All subjects underwent CAVI measurement. Serum glycated hemoglobin (HbA1c), total calcium, phosphorus, parathormone, FGF-23, Klotho, MCP-1, sclerostin, and 25-OH vitamin D were determined using standard methods.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">CAVI level was 8.22âÂ±â0.18Â m/s in diabetic CKD patients and significantly higher than in nondiabetic CKD (7.61âÂ±â0.18Â m/s) and control (7.59âÂ±â0.17Â m/s) patients. FGF-23 level was higher in the CKD groups than controls but not statistically significant. MCP-1 level was significantly higher in diabetic CKD patients. Klotho and sclerostin levels were significantly lower in diabetic CKD patients. In the whole cohort, CAVI showed positive correlations with age (râ=â0.447, pâ&lt;â0.0001), smoking (râ=â0.331, pâ=â0.035), mean arterial blood pressure (MABP; râ=â0.327, pâ&lt;â0.0001), fasting blood glucose (râ=â0.185, pâ=â0.033), and HbA1c (râ=â0.258, pâ=â0.003). Stepwise regression analysis revealed that age (pâ=â0.0001, Bâ=â0.461), MABP (pâ&lt;â0.0001, Bâ=â0.365), HbA1c (pâ=â0.003, Bâ=â0.251), and MCP-1 (pâ=â0.013, Bâ=â0.214) independently predicted CAVI levels.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicate higher CAVI levels, therefore, resulting in increased arterial stiffness in the setting of diabetic CKD. Apart from age and MABP, deranged metabolic status, especially increased HbA1c and MCP-1 levels, is also independently associated with increasing CAVI levels in CKD patients. These results emphasize the importance of metabolic control in the development of arterial stiffness in CKD patients, which is an early predictor of developing cardiovascular complications.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mert</LastName>
                    <ForeName>Mehmet</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9794-8302</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Tavas State Hospital, Denizli, Turkey. mehmetmert88@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dursun</LastName>
                    <ForeName>Belda</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nephrology, Pamukkale University Medical School, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>YaÄcÄ±</LastName>
                    <ForeName>Ahmet Baki</ForeName>
                    <Initials>AB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radiology, Pamukkale University Medical School, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ãetin KardeÅler</LastName>
                    <ForeName>AyÅen</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biochemistry, Pamukkale University Medical School, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Åenol</LastName>
                    <ForeName>Hande</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biostatistics, Pamukkale University Medical School, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Demir</LastName>
                    <ForeName>SÃ¼leyman</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biochemistry, Pamukkale University Medical School, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2015TPF025</GrantID>
                    <Agency>Pamukkale Ãniversitesi</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int Urol Nephrol</MedlineTA>
            <NlmUniqueID>0262521</NlmUniqueID>
            <ISSNLinking>0301-1623</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C422903">SOST protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>62031-54-3</RegistryNumber>
                <NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7Q7P4S7RRE</RegistryNumber>
                <NameOfSubstance UI="C416507">fibroblast growth factor 23</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.2.1.31</RegistryNumber>
                <NameOfSubstance UI="D005966">Glucuronidase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.2.1.31</RegistryNumber>
                <NameOfSubstance UI="C108871">klotho protein</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055109" MajorTopicYN="N">Ankle Brachial Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005346" MajorTopicYN="N">Fibroblast Growth Factors</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005966" MajorTopicYN="N">Glucuronidase</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059289" MajorTopicYN="N">Vascular Stiffness</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Atherosclerosis</Keyword>
            <Keyword MajorTopicYN="N">CAVI</Keyword>
            <Keyword MajorTopicYN="N">CKD</Keyword>
            <Keyword MajorTopicYN="N">DM</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">MCP-1</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31773386</ArticleId>
            <ArticleId IdType="doi">10.1007/s11255-019-02336-6</ArticleId>
            <ArticleId IdType="pii">10.1007/s11255-019-02336-6</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9820470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Atheroscler Thromb. 2006 Apr;13(2):101-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16733298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Integr Blood Press Control. 2013 Apr 30;6:27-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23667317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 2001 Mar;68(3):577-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11179006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hypertens. 2004 Mar;22(3):511-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15076156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Metabolism. 2011 Jan;60(1):78-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20667560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2001 Mar 1;10(5):537-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertens Res. 2007 Apr;30(4):335-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17541212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 1989 Feb 27;244(2):487-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2465924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2012 Oct;60(1):1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22766373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2000 Aug;58(2):684-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10916091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2003 Feb 11;107(5):690-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12578870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ J. 2007 Nov;71(11):1710-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17965489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Sep 23;351(13):1296-305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15385656</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2003 Dec 1;22(23):6267-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14633986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 1987 Sep;21(9):678-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3328650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Atheroscler Thromb. 2011;18(11):924-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21628839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephron Clin Pract. 2014;128(1-2):1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25402964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Atherosclerosis. 2005 Dec;183(2):301-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16285993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2005 Jun;45(6):1042-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15897370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Urol Nephrol. 2016 Dec;48(12):2043-2050</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27465794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Heart J. 1964 Mar;26:261-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14132030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ J. 2007 Jan;71(1):89-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17186984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2013 Jun;83(6):1159-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23389416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertens Res. 2008 Oct;31(10):1921-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19015600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Mar 10;281(10):6120-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16436388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract. 2010 Dec;64(13):1796-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20946343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ J. 2008 Feb;72(2):304-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18219171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2004 Nov 2;44(9):1812-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15519012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ter Arkh. 2015;87(6):10-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26281189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Interferon Cytokine Res. 2009 Jun;29(6):313-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19441883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bras Nefrol. 2013 Apr-Jun;35(2):147-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23812573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2006 Jun 9;344(3):780-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16631114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cardiol. 2009 Jun;53(3):317-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19477372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Res Clin Pract. 2009 Jul;85(1):30-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19398141</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Dec 7;444(7120):770-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17086194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertens Res. 2002 May;25(3):359-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12135313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomech. 1980;13(2):175-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7364778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Sep 8;281(36):26602-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16809344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cardiol. 2011 Mar;34(3):189-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21337348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1989 Mar 15;142(6):1956-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2921521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Vis. 2006 May 10;12:467-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16710171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2006 Mar;21(3):707-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16263735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2015 Feb;30(2):288-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25248363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Atheroscler Thromb. 2010 May;17(5):517-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20215706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2008 May;23(5):1697-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18174265</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>